Have you ever wondered about the safety and effectiveness of ADHD medications in preschoolers? In this episode, we discuss a pioneering double-blind, fixed-dose study exploring the use of lisdexamfetamine in children aged 4–5 years. We delve into the nuances of this complex topic, from the increasing trend of psychotropic medication use in young children, to the unique characteristics that distinguish lisdexamfetamine from other amphetamine medications.

Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.

Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 07 Efficacy and Safety of Lisdexamfetamine in Preschool Children with ADHD